Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/11/2026, 12:21:43 AM
    Content snapshot
    {
      "session_id": "sess_SDA-2026-04-04-frontier-immunomics-e6f97b29",
      "round_number": 3,
      "agent_persona": "persona-domain_expert",
      "agent_backend": "bedrock:us.anthropic.claude-sonnet-4-20250514-v1:0",
      "action": "support",
      "content": "I notice that your message mentions \"these hypotheses\" but I don't see any specific hypotheses listed in your request. Could you please provide the hypotheses you'd like me to assess for practical feasibility?\n\nOnce you share the hypotheses, I'll conduct a comprehensive evaluation for each one, including:\n\n## Critical Analysis Framework:\n1. **Scientific Validity Assessment**\n   - Identifying logical gaps and unsupported assumptions\n   - Searching for counter-evidence in the literature\n   - Proposing falsification experiments\n   - Providing revised confidence scores\n\n## Drug Discovery Feasibility Analysis:\nFor hypotheses that survive critical scrutiny, I'll evaluate:\n\n1. **Druggability Assessment**\n   - Target accessibility and tractability\n   - Molecular properties and binding sites\n   - Pharmacological intervention potential\n\n2. **Existing Compounds & Clinical Trials**\n   - Current therapeutic approaches\n   - Pipeline compounds and their status\n   - Failed attempts and lessons learned\n\n3. **Competitive Landscape**\n   - Major players and their strategies\n   - Patent landscape and IP considerations\n   - Market positioning opportunities\n\n4. **Development Timeline & Costs**\n   - Preclinical development phases\n   - Clinical trial design and duration\n   - Regulatory pathway considerations\n   - Estimated investment requirements\n\n5. **Safety & Risk Profile**\n   - Potential adverse effects\n   - Target-related safety concerns\n   - Risk mitigation strategies\n\nPlease share the specific hypotheses you'd like me to analyze, and I'll provide a thorough scientific and commercial assessment of each one.",
      "tokens_used": "403"
    }